Trent N. Smith, Chief Financial Officer of Autonomix Medical, Inc. (NASDAQ:AMIX), filed a Form 4 on September 21, 2026, disclosing the acquisition of 15,000 shares of common stock on September 3, 2026, via a restricted stock award.

Key Highlights

  • Reporting person: Trent N. Smith, CFO of Autonomix Medical, Inc.
  • Transaction date: September 3, 2026
  • Shares acquired: 15,000 shares of common stock, coded as Acquisition (A)
  • Transaction type: Restricted stock award vesting one year from the date of issuance of September 3, 2026
  • Price: No price is listed for the transaction in the filing
  • Beneficial ownership following transaction: 15,119 shares of common stock, held directly

Autonomix Medical CFO Stock Award Details and Ownership Position

According to the Form 4 filing, Trent N. Smith, serving as Chief Financial Officer of Autonomix Medical, Inc., reported the acquisition of 15,000 shares of the company's common stock on September 3, 2026. The filing indicates the transaction code as "A" (Acquisition) and lists no price associated with the award. The filing identifies this grant as a restricted stock award subject to a one-year vesting schedule from the date of issuance.

Following the reported transaction, the filing states that Smith directly beneficially owns 15,119 shares of Autonomix Medical common stock. The filing notes the award will vest one year from the September 3, 2026 issuance date. No derivative securities transactions were reported in Table II of the filing.

The Form 4 was signed by Trent Smith and dated September 21, 2026. The filing was made pursuant to Section 16(a) of the Securities Exchange Act of 1934, and indicates that the form was filed by one reporting person acting individually, not as part of a joint or group filing.

What Was Disclosed

Autonomix Medical CFO Trent N. Smith disclosed the receipt of a 15,000-share restricted stock award on September 3, 2026, with a one-year vesting period. Following the transaction, Smith's direct beneficial ownership stands at 15,119 shares of common stock.